Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cytokine flow cytometry differentiates the clinical status of multiple sclerosis (MS) patients.

Clinical and experimental immunology - 1 Mar 1999

Inogés S, Merino J, Bandrés E, De Castro P, Subirá M L, Sánchez-Ibarrola A

Abstract excerpt

In this study we have examined intracellular cytokines in peripheral blood mononuclear cells (PBMC) of MS patients by flow cytometry (cytokine flow cytometry). MS progressive patients showed an increased number of cells producing interferon-gamma (IFN-gamma) after activation with phorbol 12-myristate 13-acetate and ionomycin, compared with patients with clinically inactive forms (P < 0001) and with healthy...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CD4-Positive T-Lymphocytes
Share to CD8-Positive T-Lymphocytes

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Interferon-beta

Share to Interleukin-10

Share to Interleukin-2

Share to Ionomycin

Share to Multiple Sclerosis

Share to Tetradecanoylphorbol Acetate

Source

Open in PubMed Open full text

Identifiers

PMID: 10193428
DOI: 10.1046/j.1365-2249.1999.00816.x
PMCID: PMC1905256

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cytokine flow cytometry differentiates the clinical status of multiple sclerosis (MS) patients.PMID 10193428Read ↗

Changes of percentages in immune cells phenotypes and cytokines production during two-year IFN-beta-1a treatment in multiple sclerosis patients.Semantic proximity Read ↗

Differences in mesenchymal stem cell cytokine profiles between MS patients and healthy donors: implication for assessment of disease activity and treatment.Semantic proximity Read ↗

Monocytes in multiple sclerosis: phenotype and cytokine profile.Semantic proximity Read ↗

Activated CD8+ T cells in secondary progressive MS secrete lymphotoxin.Semantic proximity Read ↗

Increased perforin expression in multiple sclerosis patients during exacerbation of disease in peripheral blood lymphocytes.Semantic proximity Read ↗

IFNβ-1b treatment leads to changes in the B cell subset and cytokine secretion profile in patients with relapsing-remitting multiple sclerosisSemantic proximity Read ↗

Interferon-beta inhibits Th1 responses at the dendritic cell level. Relevance to multiple sclerosis.Semantic proximity Read ↗

Altered phenotype and function of blood dendritic cells in multiple sclerosis are modulated by IFN-beta and IL-10.Semantic proximity Read ↗

Cytokine gene expression in cells derived from CSF of multiple sclerosis patientsSemantic proximity Read ↗

Interferon-beta induces the development of type 2 dendritic cells.Semantic proximity Read ↗

In vitro modulation of the multiple sclerosis (MS)-associated retrovirus by cytokines: implications for MS pathogenesis.Semantic proximity Read ↗

Cytokine secretion profile of myelin basic protein-specific T cells in multiple sclerosis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.